CTLA4, cytotoxic T-lymphocyte associated protein 4, 1493
N. diseases: 722; N. variants: 24
Source: ALL
Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.504 | 0.720 | 2 | 203867991 | missense variant | A/G;T | snv | 0.42; 4.0E-06 |
|
Endocrine System Diseases | 0.090 | 1.000 | 9 | 2001 | 2019 | |||||||
|
0.623 | 0.720 | 2 | 203874196 | downstream gene variant | G/A | snv | 0.37 |
|
Eye Diseases; Immune System Diseases; Endocrine System Diseases | 0.060 | 1.000 | 6 | 2010 | 2018 | |||||||
|
0.504 | 0.720 | 2 | 203867991 | missense variant | A/G;T | snv | 0.42; 4.0E-06 |
|
Pathological Conditions, Signs and Symptoms; Digestive System Diseases | 0.050 | 1.000 | 5 | 2011 | 2017 | |||||||
|
0.504 | 0.720 | 2 | 203867991 | missense variant | A/G;T | snv | 0.42; 4.0E-06 |
|
Neoplasms | 0.050 | 1.000 | 5 | 2009 | 2018 | |||||||
|
0.623 | 0.720 | 2 | 203874196 | downstream gene variant | G/A | snv | 0.37 |
|
Pathological Conditions, Signs and Symptoms; Digestive System Diseases | 0.050 | 1.000 | 5 | 2010 | 2017 | |||||||
|
0.504 | 0.720 | 2 | 203867991 | missense variant | A/G;T | snv | 0.42; 4.0E-06 |
|
Immune System Diseases; Endocrine System Diseases | 0.030 | 1.000 | 3 | 2002 | 2009 | |||||||
|
0.504 | 0.720 | 2 | 203867991 | missense variant | A/G;T | snv | 0.42; 4.0E-06 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Eye Diseases; Skin and Connective Tissue Diseases; Stomatognathic Diseases; Cardiovascular Diseases | 0.030 | 1.000 | 3 | 2005 | 2014 | |||||||
|
0.504 | 0.720 | 2 | 203867991 | missense variant | A/G;T | snv | 0.42; 4.0E-06 |
|
Digestive System Diseases; Infections | 0.030 | 1.000 | 3 | 2014 | 2019 | |||||||
|
0.504 | 0.720 | 2 | 203867991 | missense variant | A/G;T | snv | 0.42; 4.0E-06 |
|
Digestive System Diseases; Infections | 0.030 | 1.000 | 3 | 2010 | 2019 | |||||||
|
0.504 | 0.720 | 2 | 203867991 | missense variant | A/G;T | snv | 0.42; 4.0E-06 |
|
Neoplasms | 0.030 | 1.000 | 3 | 2011 | 2019 | |||||||
|
0.504 | 0.720 | 2 | 203867991 | missense variant | A/G;T | snv | 0.42; 4.0E-06 |
|
Skin and Connective Tissue Diseases; Immune System Diseases | 0.030 | 1.000 | 3 | 2012 | 2019 | |||||||
|
0.827 | 0.160 | 2 | 203869764 | intron variant | C/T | snv | 0.41 |
|
Eye Diseases; Immune System Diseases; Endocrine System Diseases | 0.030 | 1.000 | 3 | 2010 | 2018 | |||||||
|
0.623 | 0.720 | 2 | 203874196 | downstream gene variant | G/A | snv | 0.37 |
|
0.030 | 1.000 | 3 | 2009 | 2014 | ||||||||
|
0.623 | 0.720 | 2 | 203874196 | downstream gene variant | G/A | snv | 0.37 |
|
Immune System Diseases | 0.810 | 1.000 | 3 | 2010 | 2019 | |||||||
|
0.763 | 0.440 | 2 | 203866221 | upstream gene variant | T/C | snv | 0.10 |
|
Neoplasms | 0.030 | 1.000 | 3 | 2014 | 2018 | |||||||
|
0.763 | 0.440 | 2 | 203866221 | upstream gene variant | T/C | snv | 0.10 |
|
Neoplasms | 0.030 | 1.000 | 3 | 2014 | 2018 | |||||||
|
0.504 | 0.720 | 2 | 203867991 | missense variant | A/G;T | snv | 0.42; 4.0E-06 |
|
Neoplasms; Respiratory Tract Diseases | 0.020 | 1.000 | 2 | 2011 | 2013 | |||||||
|
0.504 | 0.720 | 2 | 203867991 | missense variant | A/G;T | snv | 0.42; 4.0E-06 |
|
Digestive System Diseases; Neoplasms | 0.020 | 1.000 | 2 | 2018 | 2018 | |||||||
|
0.504 | 0.720 | 2 | 203867991 | missense variant | A/G;T | snv | 0.42; 4.0E-06 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.020 | 1.000 | 2 | 2001 | 2019 | |||||||
|
0.504 | 0.720 | 2 | 203867991 | missense variant | A/G;T | snv | 0.42; 4.0E-06 |
|
Hemic and Lymphatic Diseases | 0.020 | 1.000 | 2 | 2005 | 2016 | |||||||
|
0.504 | 0.720 | 2 | 203867991 | missense variant | A/G;T | snv | 0.42; 4.0E-06 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.020 | 1.000 | 2 | 2015 | 2018 | |||||||
|
0.504 | 0.720 | 2 | 203867991 | missense variant | A/G;T | snv | 0.42; 4.0E-06 |
|
Neoplasms | 0.020 | 1.000 | 2 | 2012 | 2013 | |||||||
|
0.504 | 0.720 | 2 | 203867991 | missense variant | A/G;T | snv | 0.42; 4.0E-06 |
|
Neoplasms | 0.020 | 1.000 | 2 | 2011 | 2019 | |||||||
|
0.504 | 0.720 | 2 | 203867991 | missense variant | A/G;T | snv | 0.42; 4.0E-06 |
|
Neoplasms | 0.020 | 1.000 | 2 | 2011 | 2019 | |||||||
|
0.504 | 0.720 | 2 | 203867991 | missense variant | A/G;T | snv | 0.42; 4.0E-06 |
|
Digestive System Diseases; Neoplasms | 0.020 | 1.000 | 2 | 2010 | 2015 |